1. Home
  2. INBS vs ACON Comparison

INBS vs ACON Comparison

Compare INBS & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Bio Solutions Inc.

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$1.62

Market Cap

6.5M

Sector

Health Care

ML Signal

HOLD

Logo Aclarion Inc.

ACON

Aclarion Inc.

HOLD

Current Price

$1.94

Market Cap

6.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
INBS
ACON
Founded
2016
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
6.6M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
INBS
ACON
Price
$1.62
$1.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 34.9K
25.7K
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 99.82
EPS
N/A
★ N/A
Revenue
★ $1,980,484.00
$75,730.00
Revenue This Year
$44.72
$44.55
Revenue Next Year
$44.26
$123.97
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 65.62
52 Week Low
$0.54
$1.85
52 Week High
$24.90
$9.36

Technical Indicators

Market Signals
Indicator
INBS
ACON
Relative Strength Index (RSI) 43.59 35.90
Support Level $1.52 N/A
Resistance Level $1.92 $3.54
Average True Range (ATR) 0.11 0.11
MACD 0.04 -0.02
Stochastic Oscillator 56.72 17.86

Price Performance

Historical Comparison
INBS
ACON

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.

Share on Social Networks: